Plus, news about Innovent Biologics and Acticor:
ProMIS Neurosciences inks $122.7M placement after sharing Alzheimer’s data: The biotech said its amyloid …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Toronto, Ontario–(Newsfile Corp. – July 3, 2024) – Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) announces a proposed private placement. The Company
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in